Sjs Investment Consulting Inc. Bausch Health Companies Inc. Transaction History
Sjs Investment Consulting Inc.
- $534 Million
- Q3 2024
A detailed history of Sjs Investment Consulting Inc. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Sjs Investment Consulting Inc. holds 30 shares of BHC stock, worth $239. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30
Previous 30
-0.0%
Holding current value
$239
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BHC
# of Institutions
255Shares Held
253MCall Options Held
5.53MPut Options Held
16.5M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$277 Million2.88% of portfolio
-
Goldentree Asset Management LP New York, NY29.4MShares$234 Million21.8% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$211 Million14.7% of portfolio
-
National Bank Of Canada15.6MShares$125 Million0.18% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$104 Million0.26% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.88B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...